Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections:: A prospective study

被引:97
作者
Sotto, A
De Boever, CM
Fabbro-Peray, P
Gouby, A
Sirot, D
Jourdan, J
机构
[1] Univ Nimes, Hop Caremeau, Serv Med Interne B, Lab Therapeut, F-30029 Nimes, France
[2] Hop Gaston Doumergue, Dept Med Informat, F-30029 Nimes, France
[3] Hop Gaston Doumergue, Microbiol Lab, F-30029 Nimes, France
[4] Fac Med Clermont Ferrand, Bacteriol Lab, F-63001 Clermont Ferrand, France
关键词
D O I
10.1128/JCM.39.2.438-444.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
From November 1998 to February 1999 we prospectively evaluated the prevalence of resistance to penicillins, cephalosporins, carbapenem, quinolones, aminoglycosides, and trimethoprim-sulfamethoxazole (SXT) in 320 Escherichia coli isolates isolated from hospitalized patients with acute urinary tract infections (UTIs). We also studied for these strains risk factors for resistance to amoxicillin-clavulanic acid (AMC), fluoroquinolones (FQs), and SXT. Resistance rates were consistent with those from major recent studies reported in the literature. Multivariate analyses selected the following factors as being significantly associated with E. coli resistance: (i) for resistance to AMC, prior (1 year) UTI (odds ratio [OR] = 2.71, P = 0.006), prior (1 year) urinary catheter (OR = 2.98, P = 0.0025), and prior (6 months) antibiotic exposure (OR = 2.68, P = 0.005); (ii) for resistance to FQs male sex (OR = 3.87, P = 0.03), with a trend toward significance for age >65 years (OR = 7.67, P = 0.06) and prior (1 year) UTI (OR = 2.98, P = 0.07); and (iii) for resistance to SXT, male sex (OR = 1.91, P = 0.046), hospitalization in an intermediate-term care unit (OR = 2.18, P = 0.008), and prior (1 year) UTI (OR = 2.03, P = 0.03). Ours results suggest that prior UTI is a common risk factor for resistance to the different antibiotics tested. Although few studies on risk factors for E. coli resistance to antibiotics have been published, careful interpretation of their findings, taking into consideration the population, infection site, and period studied, should contribute to the formulation of a better strategy that can be used to overcome antibiotic resistance.
引用
收藏
页码:438 / 444
页数:7
相关论文
共 40 条
[21]   FREQUENCY OF INHIBITOR-RESISTANT TEM BETA-LACTAMASES IN ESCHERICHIA-COLI ISOLATES FROM URINARY-TRACT INFECTIONS IN FRANCE [J].
HENQUELL, C ;
SIROT, D ;
CHANAL, C ;
DECHAMPS, C ;
CHATRON, P ;
LAFEUILLE, B ;
TEXIER, P ;
SIROT, J ;
CLUZEL, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) :707-714
[22]   MOLECULAR CHARACTERIZATION OF 9 DIFFERENT TYPES OF MUTANTS AMONG 107 INHIBITOR-RESISTANT TEM BETA-LACTAMASES FROM CLINICAL ISOLATES OF ESCHERICHIA-COLI [J].
HENQUELL, C ;
CHANAL, C ;
SIROT, D ;
LABIA, R ;
SIROT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :427-430
[23]   Increases in rates of resistance to trimethoprim [J].
Huovinen, P .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S63-S66
[24]   ANTIBIOTIC-RESISTANCE OF ESCHERICHIA-COLI IN AUVERGNE - EPIDEMIOLOGIC DATA [J].
LAURICHESSE, H ;
HENQUELL, C ;
MARCUCILLI, A ;
BIELSA, C ;
SIROT, D ;
BEYTOUT, J ;
SIROT, J .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 :526-529
[25]   Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance [J].
Lehn, N ;
StowerHoffmann, J ;
Kott, T ;
Strassner, C ;
Wagner, H ;
Kronke, M ;
SchneiderBrachert, W .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :597-602
[26]   Escherichia coli:: Epidemiology and analysis of risk factors for infections caused by resistant strains [J].
Lepelletier, D ;
Caroff, N ;
Reynaud, A ;
Richet, H .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) :548-552
[27]  
Natsch S, 1998, INFECT CONT HOSP EP, V19, P653
[28]   A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital [J].
Olesen, B ;
Kolmos, HJ ;
Orskov, F ;
Orskov, I .
JOURNAL OF HOSPITAL INFECTION, 1995, 31 (04) :295-304
[29]   RELATIONSHIP BETWEEN QUINOLONE USE AND EMERGENCE OF CIPROFLOXACIN-RESISTANT ESCHERICHIA-COLI IN BLOOD-STREAM INFECTIONS [J].
PENA, C ;
ALBAREDA, JM ;
PALLARES, R ;
PUJOL, M ;
TUBAU, F ;
ARIZA, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :520-524
[30]  
PEREZTRALLERO E, 1993, EUR J CLIN MICROBIOL, V12, P349